-- 強生（JNJ）週三宣布，最新3期臨床試驗數據顯示，Imaavy 能夠為全身型重症肌無力患者提供超過兩年的持續疾病控制。 該公司表示，這項3期臨床試驗及其開放標籤擴展研究顯示，在120週內，患者的症狀和生活品質持續改善，致病抗體水平也顯著降低，許多患者達到並維持了最低症狀水平。 強生公司也宣布，其EPIC研究（首個Imaavy與另一種FcRn阻斷劑在全身型重症肌無力治療的頭對頭比較研究）目前正在招募受試者。
Price: $226.58, Change: $+0.42, Percent Change: +0.19%
Brazilian Rare Earths (ASX:BRE) said that the mineral resource estimate and scoping study for the Rocha da Rocha critical minerals province are both targeted for mid-2026, according to a Monday Australian bourse filing.Sensor-based ore sorting testing validated a simple, dry beneficiation pathway for the Monte Alto project, while a metallurgical optimization program validated low-temperature acid-cure processing at 150 degrees celsius, with a 15 kilograms blended composite scale-up test confirming high extraction performance and strong scalability, the filing said.The company expects to submit an economic development plan for the project to Brazil's National Mining Agency in the June quarter.Brazilian Rare Earths' shares rose nearly 4% in recent trading on Monday.
CITIC Securities (HKG:6030, SHA:600030) posted net profit attributable to owners of 10.2 billion yuan for the first quarter of 2026, up 55% from 6.61 billion yuan a year earlier, according to an April 24 Hong Kong bourse filing.Hong Kong-listed shares of the firm were up nearly 2% in Monday morning trade.Earnings per share came in at 0.67 yuan, compared with 0.43 yuan in the prior-year period.Operating revenue rose 41% to 23.2 billion yuan from 16.4 billion yuan.
Zhejiang NHU's (SHE:002001) net profit attributable to shareholders in the first quarter rose 15% to 6.76 billion yuan from 5.87 billion yuan a year earlier, according to a Saturday filing on the Shenzhen bourse.Earnings per share climbed 16% year on year to 2.21 yuan from 1.91 yuan.Operating revenue increased 3% to 22.3 billion yuan from 21.6 billion yuan in the prior year.